European Medicines Agency — Medicines Shortages (EMA)

European Medicines Agency — Medicines Shortages is the official source of medicine shortage information for European Union (EU). Mederti checks its register daily and links every notice back to the original publication.

Official register

www.ema.europa.eu

Country

European Union

Notices tracked by Mederti

106

Last checked

2 Aug 2026

Latest notices from EMA

• Ifosfamide — active, high, since 2 Dec 2026 (source)
• Aztreonam — active, high, since 7 Oct 2026 (source)
• Mycobutin 150Mg Hard Capsules (Rifabutin) — active, high, since 30 Jun 2026 (source)
• Topiramate — active, high, since 29 Jun 2026 (source)
• Concentrated Motrin (Ibuprofen) Infants' Drops Oral Suspensi — active, high, since 5 Jun 2026 (source)
• Concentrate Of Proteolytic Enzymes Enriched In Bromelain — active, high, since 5 Jun 2026 (source)
• Eli Lilly Insulin (Various Forms) — active, high, since 23 Mar 2026 (source)
• Inotersen — active, high, since 7 Mar 2026 (source)
• Cyclophosphamide — active, high, since 24 Feb 2026 (source)
• Cyclophosphamide-Monohydrate — active, high, since 24 Feb 2026 (source)
• Perfusion Solutions — active, high, since 6 Dec 2025 (source)
• Eptacog Alfa (Activated) — active, high, since 5 Dec 2025 (source)
• Risperidone — active, high, since 19 Nov 2025 (source)
• Mannitol — active, high, since 14 Nov 2025 (source)
• Human-Menopausal-Gonadotrophin — active, high, since 11 Nov 2025 (source)

Mederti is not affiliated with or endorsed by European Medicines Agency — Medicines Shortages. All notices remain the property of their publisher and are linked to the original source.